138 related articles for article (PubMed ID: 26666463)
1. The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme.
Oke JL; Stratton IM; Aldington SJ; Stevens RJ; Scanlon PH
Diabet Med; 2016 Jul; 33(7):896-903. PubMed ID: 26666463
[TBL] [Abstract][Full Text] [Related]
2. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.
Younis N; Broadbent DM; Vora JP; Harding SP;
Lancet; 2003 Jan; 361(9353):195-200. PubMed ID: 12547541
[TBL] [Abstract][Full Text] [Related]
3. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland.
Looker HC; Nyangoma SO; Cromie D; Olson JA; Leese GP; Black M; Doig J; Lee N; Lindsay RS; McKnight JA; Morris AD; Philip S; Sattar N; Wild SH; Colhoun HM; ;
Diabetologia; 2012 Sep; 55(9):2335-42. PubMed ID: 22688348
[TBL] [Abstract][Full Text] [Related]
4. Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.
Scotland G; McKeigue P; Philip S; Leese GP; Olson JA; Looker HC; Colhoun HM; Javanbakht M
Diabet Med; 2016 Jul; 33(7):886-95. PubMed ID: 27040994
[TBL] [Abstract][Full Text] [Related]
5. THEIA™ development, and testing of artificial intelligence-based primary triage of diabetic retinopathy screening images in New Zealand.
Vaghefi E; Yang S; Xie L; Hill S; Schmiedel O; Murphy R; Squirrell D
Diabet Med; 2021 Apr; 38(4):e14386. PubMed ID: 32794618
[TBL] [Abstract][Full Text] [Related]
6. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme.
Looker HC; Nyangoma SO; Cromie DT; Olson JA; Leese GP; Philip S; Black MW; Doig J; Lee N; Briggs A; Hothersall EJ; Morris AD; Lindsay RS; McKnight JA; Pearson DW; Sattar NA; Wild SH; McKeigue P; Colhoun HM;
Diabetologia; 2013 Aug; 56(8):1716-25. PubMed ID: 23689796
[TBL] [Abstract][Full Text] [Related]
7. Grading and disease management in national screening for diabetic retinopathy in England and Wales.
Harding S; Greenwood R; Aldington S; Gibson J; Owens D; Taylor R; Kohner E; Scanlon P; Leese G;
Diabet Med; 2003 Dec; 20(12):965-71. PubMed ID: 14632697
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with progression to referable retinopathy: a type 2 diabetes mellitus cohort study in the Republic of Ireland.
Smith JJ; Wright DM; Scanlon P; Lois N
Diabet Med; 2020 Jun; 37(6):1000-1007. PubMed ID: 32096253
[TBL] [Abstract][Full Text] [Related]
9. An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness.
Tufail A; Kapetanakis VV; Salas-Vega S; Egan C; Rudisill C; Owen CG; Lee A; Louw V; Anderson J; Liew G; Bolter L; Bailey C; Sadda S; Taylor P; Rudnicka AR
Health Technol Assess; 2016 Dec; 20(92):1-72. PubMed ID: 27981917
[TBL] [Abstract][Full Text] [Related]
10. Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study.
Cheyne CP; Burgess PI; Broadbent DM; García-Fiñana M; Stratton IM; Criddle T; Wang A; Alshukri A; Rahni MM; Vazquez-Arango P; Vora JP; Harding SP;
Diabet Med; 2021 Sep; 38(9):e14583. PubMed ID: 33830513
[TBL] [Abstract][Full Text] [Related]
11. Screening attendance, age group and diabetic retinopathy level at first screen.
Scanlon PH; Stratton IM; Leese GP; Bachmann MO; Land M; Jones C; Ferguson B;
Diabet Med; 2016 Jul; 33(7):904-11. PubMed ID: 26337435
[TBL] [Abstract][Full Text] [Related]
12. Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine.
Eleuteri A; Fisher AC; Broadbent DM; García-Fiñana M; Cheyne CP; Wang A; Stratton IM; Gabbay M; Seddon D; Harding SP;
Diabetologia; 2017 Nov; 60(11):2174-2182. PubMed ID: 28840258
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service.
Thomas RL; Dunstan FD; Luzio SD; Chowdhury SR; North RV; Hale SL; Gibbins RL; Owens DR
Br J Ophthalmol; 2015 Jan; 99(1):64-8. PubMed ID: 25091950
[TBL] [Abstract][Full Text] [Related]
14. Agreement between photographic screening and hospital biomicroscopy grading of diabetic retinopathy and maculopathy.
Healy R; Sallam A; Jones V; Donachie PH; Scanlon PH; Stratton IM; Johnston RL
Eur J Ophthalmol; 2014; 24(4):550-8. PubMed ID: 24338579
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study.
Bellemo V; Lim ZW; Lim G; Nguyen QD; Xie Y; Yip MYT; Hamzah H; Ho J; Lee XQ; Hsu W; Lee ML; Musonda L; Chandran M; Chipalo-Mutati G; Muma M; Tan GSW; Sivaprasad S; Menon G; Wong TY; Ting DSW
Lancet Digit Health; 2019 May; 1(1):e35-e44. PubMed ID: 33323239
[TBL] [Abstract][Full Text] [Related]
16. Vibration perception threshold for sight-threatening retinopathy screening in type 2 diabetic outpatients.
Shen J; Hu Y; Liu F; Zeng H; Li L; Zhao J; Zhao J; Zheng T; Lu H; Lu F; Bao Y; Jia W
Diabetes Metab Res Rev; 2013 Oct; 29(7):525-31. PubMed ID: 23658123
[TBL] [Abstract][Full Text] [Related]
17. Detection of perimacular red dots and blots when screening for diabetic retinopathy: Refer or not refer?
Baltatescu A; Striglia E; Trento M; Mazzeo A; Cavallo F; Charrier L; Porta M
Diab Vasc Dis Res; 2018 Jul; 15(4):356-359. PubMed ID: 29775089
[TBL] [Abstract][Full Text] [Related]
18. Long-term Comparative Effectiveness of Telemedicine in Providing Diabetic Retinopathy Screening Examinations: A Randomized Clinical Trial.
Mansberger SL; Sheppler C; Barker G; Gardiner SK; Demirel S; Wooten K; Becker TM
JAMA Ophthalmol; 2015 May; 133(5):518-25. PubMed ID: 25741666
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of screening for diabetic retinopathy with two nonmydriatic digital images compared with the seven standard stereoscopic photographic fields.
Boucher MC; Gresset JA; Angioi K; Olivier S
Can J Ophthalmol; 2003 Dec; 38(7):557-68. PubMed ID: 14740797
[TBL] [Abstract][Full Text] [Related]
20. Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study.
Ochs A; McGurnaghan S; Black MW; Leese GP; Philip S; Sattar N; Styles C; Wild SH; McKeigue PM; Colhoun HM;
PLoS Med; 2019 Oct; 16(10):e1002945. PubMed ID: 31622334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
